US Equity
VCYT
— VERACYTE, INC.Veracyte, Inc. is a genomic diagnostics company that develops and commercializes molecular tests to improve diagnosis and guide treatment decisions in oncology.
💰 Market cap: $4.44B📍 6000 Shoreline Court, Suite 300, SOUTH SAN FRANCISCO, CA, 94080 US🏷️ Biotechnology & Medical Research💵 Previous close: $56.61🔢 6,532 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $56.61 |
| 2026-07-23 | $57.88 |
| 2026-07-22 | $58.01 |
| 2026-07-21 | $59.53 |
| 2026-07-20 | $57.26 |
| 2026-07-17 | $59.13 |
| 2026-07-16 | $59.22 |
| 2026-07-15 | $59.51 |
| 2026-07-14 | $56.62 |
| 2026-07-13 | $57.48 |
| 2026-07-10 | $56.97 |
| 2026-07-09 | $59.30 |
| 2026-07-08 | $56.12 |
| 2026-07-07 | $56.16 |
| 2026-07-06 | $57.99 |
| 2026-07-02 | $57.08 |
| 2026-07-01 | $59.85 |
| 2026-06-30 | $58.73 |
| 2026-06-29 | $60.19 |
| 2026-06-26 | $60.49 |
| 2026-06-25 | $58.55 |
| 2026-06-24 | $56.76 |
| 2026-06-23 | $53.79 |
| 2026-06-22 | $53.19 |
| 2026-06-18 | $53.63 |
| 2026-06-17 | $51.29 |
| 2026-06-16 | $50.92 |
| 2026-06-15 | $49.15 |
| 2026-06-12 | $47.33 |
| 2026-06-11 | $47.42 |
| 2026-06-10 | $48.17 |
| 2026-06-09 | $49.24 |
| 2026-06-08 | $47.27 |
| 2026-06-05 | $48.73 |
| 2026-06-04 | $49.94 |
| 2026-06-03 | $48.69 |
| 2026-06-02 | $47.80 |
| 2026-06-01 | $48.18 |
| 2026-05-29 | $46.34 |
| 2026-05-28 | $47.99 |
| 2026-05-27 | $44.49 |
| 2026-05-26 | $44.21 |
| 2026-05-22 | $45.03 |
| 2026-05-21 | $45.19 |
| 2026-05-20 | $45.19 |
| 2026-05-19 | $41.69 |
| 2026-05-18 | $41.50 |
| 2026-05-15 | $38.48 |
| 2026-05-14 | $38.90 |
| 2026-05-13 | $38.25 |
| 2026-05-12 | $39.56 |
| 2026-05-11 | $39.70 |
| 2026-05-08 | $40.42 |
| 2026-05-07 | $40.76 |
| 2026-05-06 | $41.19 |
| 2026-05-05 | $32.97 |
| 2026-05-04 | $33.45 |
| 2026-05-01 | $33.09 |
| 2026-04-30 | $32.92 |
| 2026-04-29 | $31.78 |
| 2026-04-28 | $33.43 |